CytoSorbents Corporation (CTSO)

[petergriffin]

Hello stockfreak.

Disagree with you on the risks being high. Certainly at these prices (around 18 cent a share), the company presents little risk IMO. It was getting riskier on no official news as we neared 30 cent but I don't expect there to be much more downside over the course of the next month. If anything the stock is going to rally again toward 22 cent range before deciding what it does next IMO. Much will depend IMO on the content of the 10Q and any accompanying PR in mid February.

I think investors and daytraders were kinda annoyed that only 45 patients are enrolled in the trial. I think everyone thought the figure was going to be 33% higher or more. It seems the magic number for Medasorb to get to is 80 and we just don't know whether they'll hit that target. Chan the CEO seems to think they will. I think he put it down to Christmas and the slow time of year and he is expecting a flurry of new recruitment over the next month to counter the poor progress recently.

From all accounts, the device works well but that is not the problem. The problem is trial recruitment numbers. If MSBT could somehow make up the trial numbers and announce positive results with their endpoints it would be a blockbuster stock IMO. Less than a 27 million float in an $8bn market per year with no real competition, we'd see in between $1 and $2 PPS easy.

I think there will probably be a new round of buying at these levels and people will hold until around the 10Q in mid Feb but if the 10Q and/or any PR to go with it fails to impress and discloses lowish patient numbers there will be another sell off at that time.

Hope that helps. You can do your own DD as well.